News

In an amended complaint, filed on February 16, 2005, Tercica and Genentech challenged Insmed’s right to commercialize SomatoKine and added allegations of infringement of an additional patent. Insmed

This collaboration will be the second HIV-related collaboration between Benitec and City of Hope. It will be funded through phase I clinical trials by a portion of a

This is the message from new, tougher guidance which has been launched at the Medicines and Healthcare products Regulatory Agency (MHRA)’s first ever seminar on advertising. Speaking about

This approval follows a positive opinion in November 2004 by the European Committee for Medicinal Products for Human Use (CHMP), the human medicines scientific body of the European

The biologics programs are for erythropoietin (EPO), a generic version of Amgen’s Epogen (epoetin-alfa) and granulocyte colony stimulating factor (G-CSF), the generic version of Amgen’s Neupogen (filgrastim). Epogen

Santarus has initiated shipments of Zegerid (omeprazole) powder for oral suspension 40mg to pharmaceutical wholesalers that distribute to retail pharmacies, hospitals and other institutional customers. This product is

The development of the next-generation human growth hormone (hGH) may allow less frequent injections of this important therapeutic protein, which is currently administered daily. Using its protein evolution

These new rapid relief results follow the announcement in June 2004, that NCX 1510 had reached the primary efficacy endpoint of a phase IIa study in patients suffering

Tarceva (erlotinib) and Iressa (gefitinib) are so-called targeted therapies, in that they halt the growth of certain cancers by zeroing in on a signaling molecule critical to the